Around 75% of breast cancer patients have estrogen receptor (ER) positive breast cancer. Endocrine-related therapies employed to treat these patients often fail due to resistance. Consequently, new therapeutic targets are needed. Myosin VI (MVI) is increasingly implicated in cancer and has been iden...
ORGANISM(S): Homo sapiens